PubMed · 1990 · 116 citations · 29 references
Sulfated Chitin DerivativesMedicinePolymer-drug ConjugateMelanomaScm-chitin IiiCancer Cell BiologyCell-matrix InteractionMetastatic Melanoma CellsTumor TargetingAnti-cancer AgentCell BiologyMatrix BiologyCancer BiologyRadiation OncologyTumor MicroenvironmentTumor BiologyType Iv CollagenExtracellular Matrix
We have investigated the effects of sulfated chitin derivatives and heparin on the invasion of B16-BL6 melanoma cells through reconstituted basement membrane Matrigel which contains laminin, type IV collagen, heparin sulfate proteoglycan, and entactin. 6-O-sulfated chitin (S-chitin) and 6-O-sulfated and carboxymethyl chitin (SCM-chitin) significantly inhibited the penetration of tumor cells through Matrigel in parallel with the increased degree of sulfation. However, 6-O- and N-sulfated but partially N-deacetylated chitin derivative (SCM-chitosan) and CM-chitin had no effect. SCM-chitin with a high degree of sulfation (SCM-chitin III), which exhibited fairly low levels of anticoagulant activity, was more effective than intact heparin. SCM-chitin III and heparin were also shown to block the attachment and migration of tumor cells to laminin-coated substrates, which are considered to be involved in tumor invasion. The inhibition of cell attachment and migration by SCM-chitin III and heparin is likely to depend upon their specific binding to laminin molecules (possibly the heparin-binding domain). Degradation of heparan sulfate by heparanase was inhibited by SCM-chitin III and heparin in a dose-dependent manner. Surprisingly, SCM-chitin III could inhibit type IV collagenolytic activity of tumor cells more potently than heparin. Thus, nontoxic SCM-chitin III of low anticoagulant properties may provide a promising basis for the prevention of cancer metastasis.
29
A rapid in vitro assay for quantitating the invasive potential of tumor cells.
Adriana Albini, Yukihide Iwamoto, Kleinman Hk et al. · PubMed · 1987 · 1.8K citations
Tumor invasion and the extracellular matrix.
Liotta La, Rao Cn, SH Barsky · PubMed · 1983 · 960 citations
Protamine is an inhibitor of angiogenesis
Stephanie Taylor, Judah Folkman · Nature · 1982 · 579 citations